Universal Ibogaine
(OTC) IBOGF
Universal Ibogaine Financials at a Glance
Market Cap
$1.37M
Revenue (TTM)
$1.54M
Net Income (TTM)
$1.65M
EPS (TTM)
$-0.00
P/E Ratio
-1.43
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.01
Volume
21,000
Open
$0.01
Price
$0.01
Volume
21,000
Open
$0.01
Previous Close
$0.01
Daily Range
$0.01 - $0.01
52-Week Range
$0.00 - $0.07
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.01
Volume
21,000
Open
$0.01
Previous Close
$0.01
Daily Range
$0.01 - $0.01
52-Week Range
$0.00 - $0.07
IBOGF News
IBOGF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Universal Ibogaine
Industry
Healthcare Providers and Services
Sector
Health CareCEO
Nicholas Peter Karos
Website
www.universalibogaine.comHeadquarters
Calgary, AB T2P 4H2, CA
IBOGF Financials
Key Financial Metrics (TTM)
Gross Margin
9%
Operating Margin
25%
Net Income Margin
-35%
Return on Equity
-161%
Return on Capital
13%
Return on Assets
-9%
Earnings Yield
-69.93%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.37M
Shares Outstanding
274.83M
Volume
21.00K
Short Interest
0.00%
Avg. Volume
136.51K
Financials (TTM)
Gross Profit
$1.07M
Operating Income
$497.15K
EBITDA
$4.61M
Operating Cash Flow
$4.33M
Capital Expenditure
$95.68K
Free Cash Flow
$4.43M
Cash & ST Invst.
$726.05K
Total Debt
$1.74M
Universal Ibogaine Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$700.92K
N/A
Gross Profit
$700.92K
N/A
Gross Margin
100.00%
N/A
Market Cap
$1.37M
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
$66.20K
+92.1%
EBITDA
$52.88K
+107.3%
Quarterly Fundamentals
Net Cash
$2.44M
-53.2%
Accounts Receivable
$608.26K
+421.8%
Inventory
$0.00
N/A
Long Term Debt
$1.72M
+130.2%
Short Term Debt
$848.92K
-45.3%
Return on Assets
-9.25%
N/A
Return on Invested Capital
13.35%
N/A
Free Cash Flow
$110.36K
+81.4%
Operating Cash Flow
$110.36K
+75.5%